TNFSF10 and neoplasm: In order to further explore the clinical value of TNFSF10 in anti-tumor immunity, we used the TIDE algorithm for predictive analysis, and we found that the expression of TNFSF10 was higher in patients who could benefit from SKCM immunotherapy.